Oregon Health and Sciences University has been on the forefront of using the genetic editing technique known as CRISPR for years. Now, they have successfully used CRISPR to edit the genes in patients with a rare eye disease. Mark Pennesi is a professor of ophthalmology at OHSU, and Carlene Knight is one of the patients who received this treatment.